Sensi SL

References (3)

Title : Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit - Hoilund-Carlsen_2024_Ageing.Res.Rev__102348
Author(s) : Hoilund-Carlsen PF , Alavi A , Barrio JR , Castellani RJ , Costa T , Herrup K , Kepp KP , Neve RL , Perry G , Revheim ME , Robakis NK , Sensi SL , Vissel B
Ref : Ageing Res Rev , :102348 , 2024
Abstract :
PubMedSearch : Hoilund-Carlsen_2024_Ageing.Res.Rev__102348
PubMedID: 38830549

Title : A Stage-Based Approach to Therapy in Parkinson's Disease - Carrarini_2019_Biomolecules_9_
Author(s) : Carrarini C , Russo M , Dono F , Di Pietro M , Rispoli MG , Di Stefano V , Ferri L , Barbone F , Vitale M , Thomas A , Sensi SL , Onofrj M , Bonanni L
Ref : Biomolecules , 9 : , 2019
Abstract :
PubMedSearch : Carrarini_2019_Biomolecules_9_
PubMedID: 31434341

Title : Brain monoglyceride lipase participating in endocannabinoid inactivation - Dinh_2002_Proc.Natl.Acad.Sci.U.S.A_99_10819
Author(s) : Dinh TP , Carpenter D , Leslie FM , Freund TF , Katona I , Sensi SL , Kathuria S , Piomelli D
Ref : Proceedings of the National Academy of Sciences of the United States of America , 99 :10819 , 2002
Abstract :
PubMedSearch : Dinh_2002_Proc.Natl.Acad.Sci.U.S.A_99_10819
PubMedID: 12136125
Gene_locus related to this paper: ratno-MGLL